CardioDx, Inc. Announces Publication of the IMPACT-CARD Trial Demonstrating Use of Corus® CAD Test Influenced Cardiologists' Clinical Management of Patients with Symptoms Suggestive of Obstructive Coronary Artery Disease
5/21/2013 9:34:26 AM
More...
|
CardioDx, Inc. Announces New Data Demonstrating Use of Corus® CAD in the Primary Care Setting for Evaluation of Symptomatic Patients With Suspected CAD Influences Clinical Decision Making
5/20/2013 9:45:42 AM
More...
|
CardioDx, Inc. Receives College of American Pathologists (CAP) Accreditation
5/10/2013 9:13:31 AM
More...
|
CardioDx, Inc. and Core Diagnostics India Announce Exclusive Corus® CAD Product Marketing and Sales Agreement
4/25/2013 11:23:50 AM
More...
|
CardioDx, Inc. to Present at the 12th Annual Needham Healthcare Conference
4/23/2013 7:36:57 AM
More...
|
CardioDx, Inc. Release: Study Finds Corus CAD to be More Accurate in Excluding the Diagnosis of Obstructive Coronary Artery Disease in Women than Standard Diagnostic Methods
3/26/2013 9:09:15 AM
More...
|
CardioDx, Inc. Release: Data Presented at American College of Cardiology 2013 Confirms Use of Corus&#-174 CAD in Women With Suspected Obstructive Coronary Artery Disease Influences Patient Management Decisions
3/11/2013 10:27:43 AM
More...
|
CardioDx, Inc. to Present Sex-Specific Data on Value of Corus® CAD in Influencing Diagnostic Strategy for Women with Suspected Obstructive Coronary Artery Disease at the 2013 American College of Cardiology Meeting
3/5/2013 1:07:00 PM
More...
|
CardioDx, Inc. to Present at Cowen and Company 33rd Annual Healthcare Conference
2/25/2013 6:46:56 AM
More...
|
CardioDx, Inc. Announces Publication of COMPASS Study Demonstrating the Corus® CAD Test Outperforms Myocardial Perfusion Imaging in Overall Diagnostic Accuracy for Obstructive Coronary Artery Disease
2/19/2013 11:58:28 AM
More...
|
|